The C6 tumors predict the worst prognosis with increased TGF-β expression and are associated with increased tumor cell migration and activation of immune suppression from the tumor stroma in breast cancer.[43, 44] Only HR+ HER2− immune-high tumors had the C6 immune environment (Fig. 2Bii). The gene discussed is ERBB2; the disease is breast cancer.